2 hours ago
Novo Nordisk (NVO) Stock — Higher-Dose Wegovy Cleared by FDA to Counter Eli Lilly Competition
FDA approves higher 7.2mg Wegovy dose for Novo Nordisk (NVO), showing 20.7% weight loss. April launch aims to challenge Eli Lilly's Zepbound dominance.
The post Novo Nordisk (NVO) Stock — Higher-Dose Wegovy Cleared by FDA to Counter Eli Lilly Competition appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Figma (FIG) Shares Tumble 8% as Google Unveils Enhanced Stitch AI Design Platfor...
- 2 hours ago
GE Aerospace (GE) Pours €110M Into European Facilities Despite Stock Dip
- 2 hours ago
Oil Prices Soar Past $109 as Iranian Strikes Target Shell and Exxon Energy Sites
- 2 hours ago
Oil Soars Past $109 as Iranian Strikes Target Shell and Exxon Energy Sites
- 2 hours ago
Netflix (NFLX) Stock Tumbles as Subscriber Growth Stalls and Content Budget Ball...